Articles tagged with Enzymes
Chemists at Ohio State University have successfully tested molecules against HIV and Hepatitis C virus RNA, mimicking natural enzymes to break apart target molecules. The complexes could produce fewer side effects and combat drug resistance, potentially leading to the development of multi-functional drugs
A team of researchers has discovered a molecular missing link that explains why fasting brings on acute attacks of the genetic disease hepatic porphyria. Fasting increases levels of PGC-1a, which regulates the activity of an enzyme in the heme production pathway, leading to toxic buildup of precursor molecules.
A new technique called piggyBac has been developed to systematically inactivate genes in the mouse genome, enabling researchers to understand the functions of individual genes. This method uses a reliable gene-transposing tool that can insert itself into the genomes of human and mouse cells.
UT Southwestern researchers discovered how a protein called nicastrin is involved in the production of beta-amyloid, a key suspect in Alzheimer's disease. By targeting just this portion of the enzyme, they hope to create treatments that block the formation of amyloid plaques without affecting other essential functions.
Researchers at UCLA have identified Rpe65 as a crucial enzyme in the regeneration of rhodopsin visual pigment in the retina after light exposure. This breakthrough could lead to a gene therapy cure for Leber congenital amaurosis, an inherited disease causing up to 20% of childhood blindness.
Researchers found that knocking out laccase-2 enzyme prevents tanning in red flour beetle, revealing protein responsible for hardened exoskeleton. The discovery opens possibilities for developing new insecticides and bio-rational methods to control pest populations.
Researchers have identified three small molecules that can inhibit the enzyme CDK5, which contributes to the development of Alzheimer's disease. The discovery is promising news for the development of new treatments for the disease.
A team of researchers developed a microreactor that continuously regenerates essential cofactors through enzyme-catalyzed reactions, driving favorable reaction equilibria. This innovation enables the efficient biocatalytic synthesis of chiral fine chemicals in larger quantities.
A study analyzing reports of suspected drug-induced liver injury found that AST and bilirubin levels are key predictors of death or liver transplant in patients with severe drug-induced liver disease. Patients with hepatocellular liver damage had a higher mortality rate, highlighting the importance of monitoring these biomarkers.
Researchers found a unique salt-tolerant enzyme in algae that shares structural similarities with human kidney enzymes. This discovery may lead to the development of new drugs targeting enzyme-based treatments.
Researchers found that the p16 gene inactivates key enzymes JNK 1 and JNK 2, keeping them from activating proteins that promote cell growth. A small protein mimicking p16 has been designed to mimic its action, showing promise for anti-cancer activity.
Researchers at UT Southwestern discovered that WNK1 activates SGK1, leading to sodium ion channel activation and increased blood pressure. The study suggests that genetic factors may play a role in salt-sensitive hypertension., Genetic factors may contribute to hypertension in certain population groups.
Researchers at UT Southwestern Medical Center discovered a vicious cycle of protein formation involving alpha-synuclein, leading to fibril formation and further protein clumping. The study suggests that inhibiting the malicious form of an enzyme could potentially lead to new treatment avenues for Parkinson's disease.
Researchers have discovered a new enzyme family that plays a role in Alzheimer's disease, generating toxic molecules called amyloid-beta peptides. The study uses genetically-engineered mice to show that the toxic activity of this enzyme can be separated from its other benign activities.
Researchers used genetic engineering techniques to develop mice with overexpressed PKC-beta 2, demonstrating its role in the progression of diabetic kidney disease. The study found that albumin levels were tenfold higher and oxidative stress three times higher in these mice compared to normal mice.
Researchers at UIC are developing protease inhibitors to block the SARS virus's advance, aiming to reduce viral load and ameliorate disease. The targeted approach, focusing on the backbone of enzymes, is designed to evade mutations that may hinder drug effectiveness.
The new process, developed by Michael Wong and his team, involves mixing polymer, salt, and tiny silica particles to create hollow spheres that can encapsulate drugs, flavor compounds, and other molecular cargo. The microcapsules have potential applications in drug delivery, medical imaging, and enzyme protection.
A new enzyme group has been identified that attaches an unusual molecular tag to microtubules, directing motor proteins to specific destinations. This discovery paves the way for further research on polyglutamylate modification and its role in cellular traffic.
Researchers have solved the co-crystal structure of the Dam enzyme in complex with DNA, revealing its role in regulating bacterial virulence. The study offers a potential target for designing rationally designed drugs to inhibit this enzyme's chemical reaction or DNA binding process.
A new study suggests that eliminating the enzyme ACAT2 could dramatically reduce cardiovascular disease risk. Research in animals shows that cholesterol altered by ACAT2 is more likely to build up in blood vessel walls and cause atherosclerosis.
Researchers from Imperial College London identified an enzyme called IKKá, which acts as a 'brake' on immune cell pathways. By inhibiting IKKa activity, the body's ability to fight off infection increased, but also led to higher inflammatory responses.
Researchers discovered that a 'fickle' enzyme plays both protective and detrimental roles in the heart. When its cofactor is present, it helps regulate blood flow and heart function, but without it, the enzyme produces factors contributing to oxidative stress.
Researchers identified cathepsin B and L as essential enzymes for Ebola virus reproduction, shedding light on its infection mechanism. Inhibiting these enzymes could lead to the development of a broad-spectrum antiviral therapy against multiple hemorrhagic fever viruses.
Researchers have identified the KMO enzyme as a potential therapeutic target for Huntington's disease, with a chemical compound already available to inhibit its activity. The discovery could take research in a new direction towards microglial cells, which are thought to play an important role in the progression of the disease.
A high-throughput screening method using automated imaging and bioinformatics has identified a novel compound with promising potential as an anticancer agent. The compound, hydroxy-PP, targets carbonyl reductase 1, an enzyme involved in chemotherapy-related cardiotoxicity.
A recent UCSF study has identified a genetic mutation in the casein kinase1 delta (CK1 delta) gene that is associated with familial advanced sleep phase syndrome (FASPS), a rare sleep disorder. The research, published in Nature, also suggests that circadian rhythm variants may contribute to psychiatric disorders such as depression.
Researchers have identified a missing enzyme in M. tuberculosis that plays a crucial role in the bacterium's ability to acquire iron through mycobactin synthesis. This discovery highlights the importance of understanding the iron scavenging pathway in TB and provides new avenues for developing effective anti-TB drugs.
Researchers at Duke University Medical Center have successfully reversed glycogen buildup in heart and skeletal muscle of genetically altered mice using a muscle-targeted gene therapy. This approach shows promise as a potential treatment strategy for Pompe disease patients who fail to respond to enzyme replacement therapy.
Cancer cells' DNA is tightly compacted, making it resistant to enzyme digestion, unlike healthy tissue. The study's findings suggest new diagnostic and therapeutic tools for distinguishing different types of tumors.
Researchers at Imperial College London have solved the structure of the Foot-and-Mouth Disease Virus enzyme, revealing its atomic details and potential target for anti-viral drugs. The discovery could lead to the development of a vaccine that can be administered quickly to control outbreaks.
Researchers discovered RNA loops and knots play a crucial role in A-to-I RNA recoding, enabling species-specific editing of proteins. By understanding these molecular structures, scientists can gain insights into the genetic code and improve our ability to interpret genome information.
Researchers have discovered a method to store biomaterials in cells' natural vaults, enabling targeted drug delivery and gene editing. This approach may prove safer than traditional methods by minimizing the risk of an immune response.
Tufts-NEMC researchers have discovered a key enzyme responsible for cancer cell growth and invasion, which can be blocked by new compounds called pepducins. The finding provides a novel therapeutic approach for treating invasive cancers.
Researchers at UT Southwestern have discovered that aconitase, an enzyme involved in energy production, plays a crucial role in maintaining the integrity of the mitochondrial genome. This finding reveals a new function for the enzyme, independent of its metabolic activity.
Researchers discovered that a lack of enzyme ACC2 turns fat cells into fat burners, leading to increased oxidation of fatty acids and glucose. This transformation contributes to improved energy maintenance and reduced risk of type 2 diabetes.
Researchers isolated a highly reactive iron-sulfur complex from a bacterium, which outperforms current industrial catalysts in reactivity. The discovery could lead to the development of new, more efficient chemical processes and materials.
Researchers found that increasing one skill can significantly impact others, with some activities dropping and others increasing in levels. The primary function of the enzymes remained largely unchanged despite changes in other promiscuous traits.
Researchers at Stanford University have solved part of the puzzle on how Botox works by binding to specific sites on proteins called SNAREs, preventing muscle contraction and paralysis. The study could help develop alternative treatments for botulism and find new medical applications for Botox and other neurotoxins.
Scientists found that animals with extra copies of the AMP-1 enzyme lived 13% longer than controls, while environmental stressors activating AMP-1 also led to longer lives. The study's findings have broad implications for understanding human aging and potentially extending lifespan through exercise and therapeutics.
Scientists have discovered a defense mechanism in certain plant species that were believed to be bred out of existence due to human selection. The study found that a specific enzyme and protein complex work together to defend against insect attacks, but their activity is suppressed in plants bred for desirable traits.
Researchers found that sperm motility and ATP production depend on a metabolic pathway called glycolysis, which uses sugar to produce energy. Without the enzyme glyceraldehyde 3-phosphate dehydrogenase-S (GAPDS), sperm movement is severely impaired, making it a potential target for non-hormonal male contraceptives.
Researchers at Cardiff University have identified an oxygen-sensing molecule, hemoxygenase-2, which helps the brain adjust breathing rates in response to low oxygen levels. The discovery has important implications for understanding and treating conditions where oxygen levels are scarce, such as following a stroke or during birth.
New research from Newcastle University found that green and black tea inhibit the activity of certain enzymes in the brain linked to memory decline. The study suggests that drinking regular cups of tea may help improve memory and slow the development of Alzheimer's disease.
Researchers at INEEL isolated a stable catalase enzyme from T. brockianus, improving industrial half-life by 86,000-fold, reducing environmental costs and toxicity associated with chlorine-based bleaching processes.
Researchers discovered that MMP-1 operates as an extracellular molecular motor converting chemical energy into motion by breaking collagen bonds. This process contributes to tissue growth, development, and repair, and may even aid in cancerous invasion.
A study by Yale University researchers reveals that lowering a specific lipid in nerve terminals affects neurotransmitter exchange between neurons. The findings have implications for understanding synaptic transmission and potentially developing new treatments for diseases like Down syndrome, cancer, and diabetes.
Researchers at St. Jude Children's Research Hospital have uncovered the structure of an enzyme that produces folate, a nutrient essential for bacterial survival. The team created images of the molecular structure using X-ray crystallography and discovered a new target for drugs that could avoid antibiotic resistance in anthrax bacteria.
Researchers have successfully synthesized the 22nd amino acid, L-pyrrolysine, and demonstrated its incorporation into new proteins within E. coli bacteria. The discovery explains how this amino acid is inserted into proteins inside living cells, following a traditional path that had been predicted by scientists.
Researchers have discovered that DNA stimulates the activity of a viral enzyme, providing a potential new target for antiviral drugs. The discovery could help prevent adenovirus infections, which can cause respiratory, gastrointestinal, and eye infections, including blindness.
The study reveals that VAMP8 is essential for the normal functioning of pancreatic acinar cells, which produce digestive enzymes. Mice lacking VAMP8 showed reduced levels of digestive enzymes and partial resistance to pancreatitis, suggesting a potential link between VAMP8 and this condition.
Researchers at St. Jude Children's Research Hospital have discovered the structure and function of the 'tail' of a protein essential for cell replication, revealing potential targets for new anticancer drugs. The study found that a slight modification in the protein's shape can create unique enzyme activity.
A20, an enzyme that regulates the immune system's response to bacterial infections, prevents over-reactions of the immune system to blood infections known as sepsis. The research shows A20 also controls the immune reaction that can cause inflammatory bowel disease.
Researchers discovered that Streptococcal bacteria use an enzyme called streptokinase to block the human blood clotting response and spread within the body. The study found that subtle variations in plasminogen genes may explain why some people are more susceptible to strep infections.
A recent simulation study revealed that damaged DNA becomes more susceptible to bending due to a reorganization of its sugar-phosphate backbone. This change allows the molecule to bend easily, which is recognized by enzymes as a damaged site.
Saint Louis University researchers discovered that the blood-brain barrier has a transport system for enzymes that is lost with aging. This discovery opens up new possibilities for treating lysosomal storage diseases by targeting the blood-brain barrier's delivery mechanism.
A team of scientists has identified an enzyme called CYP4AW1 that breaks down insect pheromones, allowing for the development of targeted treatments to prevent agricultural pests from breeding. By blocking this enzyme with a specific chemical, researchers may be able to disrupt the communication between insects and prevent infestations.
Researchers have identified viral proteins that can kill specific bacteria, such as Streptococcus pneumoniae and Staphylococcus aureus, which cause various infections. These enzymes can be delivered orally or nasally to decolonize individuals in high-risk settings.
Researchers at Brown Medical School have discovered two key enzymes, PC1 and PC2, that play a crucial role in processing the precursor of thyrotropin-releasing hormone (TRH) and regulating calorie-burning. This finding will aid in the understanding and treatment of obesity, which affects nearly 68 million adults in the United States.
Research finds that leptin controls hypothalamic prohormone convertases 1 and 2, influencing thyrotopin-releasing hormone production. This regulation plays a key role in energy balance and may lead to novel treatments for obesity and thyroid axis disorders.
Researchers found a nematode's oxygen-sensing mechanism can regulate blood pressure. The discovery reveals that worms prefer lower oxygen concentrations, which may explain their unique behavior.